These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37965898)

  • 61. The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment.
    Grimm SE; Strong M; Brennan A; Wailoo AJ
    Pharmacoeconomics; 2017 Dec; 35(12):1287-1296. PubMed ID: 28849538
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body.
    Arntsen KA; Blount LG; Dickerson BJ; Koola CP; Venable Y; Wildman P
    Int J Technol Assess Health Care; 2022 Oct; 38(1):e76. PubMed ID: 36263665
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".
    Kim H; Goodall S; Liew D
    Int J Health Policy Manag; 2021 Feb; 10(2):98-101. PubMed ID: 32610777
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence-based decision-making 3: Health technology assessment.
    O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The potential use of digital health technologies in the African context: a systematic review of evidence from Ethiopia.
    Manyazewal T; Woldeamanuel Y; Blumberg HM; Fekadu A; Marconi VC
    NPJ Digit Med; 2021 Aug; 4(1):125. PubMed ID: 34404895
    [TBL] [Abstract][Full Text] [Related]  

  • 69. International comparison of comparative effectiveness research in five jurisdictions: insights for the US.
    Levy AR; Mitton C; Johnston KM; Harrigan B; Briggs AH
    Pharmacoeconomics; 2010; 28(10):813-30. PubMed ID: 20831289
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evolution of the clinical simulation approach to assess digital health technologies.
    Lau K; Halligan J; Fontana G; Guo C; O'Driscoll FK; Prime M; Ghafur S
    Future Healthc J; 2023 Jul; 10(2):173-175. PubMed ID: 37786639
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Information Quality Frameworks for Digital Health Technologies: Systematic Review.
    Fadahunsi KP; O'Connor S; Akinlua JT; Wark PA; Gallagher J; Carroll C; Car J; Majeed A; O'Donoghue J
    J Med Internet Res; 2021 May; 23(5):e23479. PubMed ID: 33835034
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Methodological Frameworks and Dimensions to Be Taken Into Consideration in Digital Health Technology Assessment: Protocol for a Scoping Review.
    Segur-Ferrer J; Moltó-Puigmartí C; Pastells-Peiró R; Vivanco-Hidalgo RM
    JMIR Res Protoc; 2022 Oct; 11(10):e39905. PubMed ID: 36222788
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.
    Farah L; Davaze-Schneider J; Martin T; Nguyen P; Borget I; Martelli N
    Artif Intell Med; 2023 Jun; 140():102547. PubMed ID: 37210155
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expanding the Role of Early Health Economic Modelling in Evaluation of Health Technologies Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".
    Federici C; Torbica A
    Int J Health Policy Manag; 2021 Feb; 10(2):102-105. PubMed ID: 32610778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Barriers to and Facilitators of Digital Health Among Culturally and Linguistically Diverse Populations: Qualitative Systematic Review.
    Whitehead L; Talevski J; Fatehi F; Beauchamp A
    J Med Internet Res; 2023 Feb; 25():e42719. PubMed ID: 36853742
    [TBL] [Abstract][Full Text] [Related]  

  • 77. How digital health technologies promote healthy life in the Post-COVID-19 Era: evidences from national survey on Chinese adolescents and youngsters.
    Li X; Zhang M
    Front Public Health; 2023; 11():1135313. PubMed ID: 37228730
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.
    Lord J; Willis S; Eatock J; Tappenden P; Trapero-Bertran M; Miners A; Crossan C; Westby M; Anagnostou A; Taylor S; Mavranezouli I; Wonderling D; Alderson P; Ruiz F
    Health Technol Assess; 2013 Dec; 17(58):v-vi, 1-192. PubMed ID: 24325843
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Main Challenges of Incorporating Environmental Impacts in the Economic Evaluation of Health Technology Assessment: A Scoping Review.
    Guirado-Fuentes C; Abt-Sacks A; Trujillo-Martín MDM; García-Pérez L; Rodríguez-Rodríguez L; Carrion I Ribas C; Serrano-Aguilar P
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981859
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.